The USP and National Formulary (USP-NF) is the US legally recognised standards compendia for drugs, drug products and dietary supplements.
Dr Foster, as the chairman of the committee is expected to take up the responcibilities which include the creation of new standard USP General chapters as well as the revision of current standard general chapters.
Catalent said that the initial focus of the committee is expected to be development of standards to guide the pharmaceutical industry in the supply chain, inclusive of drug pedigrees and anti-counterfeiting; testing for extractables and leachables; and testing of glass, plastic and metal container closure systems.
Dr Foster took up the responsibility of building external relationships with regulatory bodies and pharmacopeia working groups within the pharmaceutical/biotechnology and consumer healthcare industries. Dr Foster has been with Catalent for 20 years having served in various quality and regulatory roles.
Dr Foster said: “It is an honor to be elected to the USP Council of Experts Chair of the Packaging, Storage and Distribution Committee.”
Sharon Johnson, senior vice president of quality at Catalent, said: “We are pleased to be able to have our experts engage with and support industry bodies such as the USP.”